학술논문

165MO Trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients (pts) with active brain metastases: Primary outcome analysis from the TUXEDO-1 trial
Document Type
Abstract
Source
In Annals of Oncology May 2022 33 Supplement 3:S198-S198
Subject
Language
ISSN
0923-7534